Other Income & Expense
Other Income (Expense)
Moderna Other Income (Expense) decreased by 50.0% to -$18.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 350.0%, from -$4.00M to -$18.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a -27.5% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.00M | -$10.00M | -$7.00M | -$13.00M | -$13.00M | -$7.00M | -$12.00M | -$48.00M | $14.00M | -$51.00M | -$39.00M | -$19.00M | -$27.00M | -$12.00M | -$29.00M | -$4.00M | $8.00M | $0.00 | -$12.00M | -$18.00M |
| QoQ Change | — | -400.0% | +30.0% | -85.7% | +0.0% | +46.2% | -71.4% | -300.0% | +129.2% | -464.3% | +23.5% | +51.3% | -42.1% | +55.6% | -141.7% | +86.2% | +300.0% | -100.0% | — | -50.0% |
| YoY Change | — | — | — | — | -550.0% | +30.0% | -71.4% | -269.2% | +207.7% | -628.6% | -225.0% | +60.4% | -292.9% | +76.5% | +25.6% | +78.9% | +129.6% | +100.0% | +58.6% | -350.0% |
Range-$51.00M – $14.00M
CAGR+58.8%
Avg YoY Growth-101.2%
Median YoY Growth+27.8%
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Moderna's other income (expense)?
- Moderna (MRNA) reported other income (expense) of -$18.00M in Q1 2026.
- How has Moderna's other income (expense) changed year-over-year?
- Moderna's other income (expense) decreased by 350.0% year-over-year, from -$4.00M to -$18.00M.
- What is the long-term trend for Moderna's other income (expense)?
- Over 4 years (2021 to 2025), Moderna's other income (expense) has grown at a -27.5% compound annual growth rate (CAGR), from -$29.00M to -$8.00M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.